Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review
Authors
Koss-Mikołajczyk, IzabelaTodorović, Vanja

Šobajić, Slađana

Mahajna, Jamal
Gerić, Marko
Tur, Josep A.
Bartoszek, Agnieszka
Article (Published version)
Metadata
Show full item recordAbstract
Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic—doxorubicin—as the oxidative stress- and cardiotoxicity-inducing agent.
Keywords:
Antioxidants / Anthracyclines / Cardioprotectants / Cardiotoxicity / PhytochemicalsSource:
International Journal of Molecular Sciences, 2021, 22, 18Publisher:
- MDPI
Funding / projects:
- the project, Antioxidant Power Series as a tool for ra-tional design and assessment of health-promoting properties of functional food based on antiox-idant phytochemicals” (application No 2014/14/A/ST4/00640) financed by National Science Centre
- the official funding agency for biomedical research of the Spanish government, Institute of Health Carlos III (ISCIII),through the Fondo de Investigación para la Salud (FIS), which is co-funded by the Euro-pean Regional Development Fund (Projects 11/01791, 14/00636 and 17/01827
- Red Pred-imed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038)
- Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 200161 (University of Belgrade, Faculty of Pharmacy) (RS-200161)
DOI: 10.3390/ijms221810037
ISSN: 1661-6596
WoS: 000699607500001
Scopus: 2-s2.0-85115063451
Collections
Institution/Community
PharmacyTY - JOUR AU - Koss-Mikołajczyk, Izabela AU - Todorović, Vanja AU - Šobajić, Slađana AU - Mahajna, Jamal AU - Gerić, Marko AU - Tur, Josep A. AU - Bartoszek, Agnieszka PY - 2021 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3971 AB - Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic—doxorubicin—as the oxidative stress- and cardiotoxicity-inducing agent. PB - MDPI T2 - International Journal of Molecular Sciences T1 - Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review VL - 22 IS - 18 DO - 10.3390/ijms221810037 ER -
@article{ author = "Koss-Mikołajczyk, Izabela and Todorović, Vanja and Šobajić, Slađana and Mahajna, Jamal and Gerić, Marko and Tur, Josep A. and Bartoszek, Agnieszka", year = "2021", abstract = "Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic—doxorubicin—as the oxidative stress- and cardiotoxicity-inducing agent.", publisher = "MDPI", journal = "International Journal of Molecular Sciences", title = "Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review", volume = "22", number = "18", doi = "10.3390/ijms221810037" }
Koss-Mikołajczyk, I., Todorović, V., Šobajić, S., Mahajna, J., Gerić, M., Tur, J. A.,& Bartoszek, A.. (2021). Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review. in International Journal of Molecular Sciences MDPI., 22(18). https://doi.org/10.3390/ijms221810037
Koss-Mikołajczyk I, Todorović V, Šobajić S, Mahajna J, Gerić M, Tur JA, Bartoszek A. Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review. in International Journal of Molecular Sciences. 2021;22(18). doi:10.3390/ijms221810037 .
Koss-Mikołajczyk, Izabela, Todorović, Vanja, Šobajić, Slađana, Mahajna, Jamal, Gerić, Marko, Tur, Josep A., Bartoszek, Agnieszka, "Natural products counteracting cardiotoxicity during cancer chemotherapy: The special case of doxorubicin, a comprehensive review" in International Journal of Molecular Sciences, 22, no. 18 (2021), https://doi.org/10.3390/ijms221810037 . .